Background The most common type of metachromatic leukodystrophy (MLD) is an inherited lysosomal disorder caused by recessive mutations in ARSA. The biological process of MLD disease caused by candidate pathogenic mutations in the ARSA gene remains unclear.
Introduction
Metachromatic leukodystrophy (MLD) is an inherited lysosomal disorder caused by recessive gene mutations in ARSA and PSAP. [1] [2] [3] [4] It is recognized that there are 5 allelic forms of MLD (MIM ID: 250100), including late-infantile, juvenile, adult, partial cerebroside sulfate deficiency, and pseudoarylsulfatase A deficiency; [3] [4] and 2 nonallelic forms, including metachromatic leukodystrophy due to saposin B deficiency (MIM ID: 249900) and multiple sulfatase deficiency or juvenile sulfatidosis (MIM ID: 272200), a disorder that combines features of a mucopolysaccharidosis with those of metachromatic leukodystrophy. MLD is a rare disorder with an estimated birth prevalence of 1.4 to 1.8 per 100,000; there are also reports of 1/40,000 to 1/170,000. [5] [6] Although a series of potential therapies, such as haematopoietic stem cell transplantation, 7 enzyme replacement therapy 8 and gene therapy 9 have been explored, currently there is no curative treatment for this disease.
The most common type of MLD disease is an autosomal recessive inherited lysosomal disorder caused by mutations in the ARSA gene, located on chromosome 22q13. 33, resulting in a deficiency of the enzyme arylsulfatase A. The low activity of arylsulfatase A results in the accumulation of sulfatides in the central and peripheral nervous systems, leading to demyelination. 1 To date more than 200 ARSA allele types have been reported as ARSA-causative variants. 10 Whole-exome sequencing (WES) is a genomic analysis technique that captures and sequences all exons in the whole genome. It is widely used for the auxiliary diagnosis of monogenic diseases and hereditary complex diseases. 11 Studies have recommended WES as the preferred diagnostic procedure to detect potential pathogenic genetic variants in affected individuals with genetic characteristics but without clear MLD clinical diagnosis, combined with biochemical, enzymatic or imaging studies to complete the final diagnosis. 12 RNA sequencing (RNA-seq) is an effective method to obtain the transcriptome of life embodied in status. 13 Besides of expression status of single genes, more complex physiological processes can be reflected via system biology approaches, such as weighted gene co-expression network analysis (WGCNA). By using WGCNA gene expression data can be transformed into co-expression modules, which provide insights into signalling networks that may be responsible for phenotypic traits of interest. 14 Moreover, hub genes analysed from co-expression modules are quite helpful for the identification of candidate biomarkers or therapeutic targets. [15] [16] Combined with protein-protein interaction (PPI) information, co-expression modules also provide valuable clues to reveal the dynamic protein complexes.
Protein complexes are of great importance for understanding the principles of cellular organization and function. 17 In current study, we reported a Chinese family with a 2-year-old boy who could not sit or walk independently. By using WES technology we identified a missense mutation in exon 5 of the ARSA gene (c.925G>A homozygous mutation) in the proband and supported the clinical diagnosis of MLD. The mutation site was first reported in Asia, a systematics literature review and bioinformatics analyses were carried out to estimate its pathogenicity. A series of ARSA-mutant cell models were consequently constructed to simulate the cell state of homozygous-mutant patients and RNA-seq and system biology analysis were performed to explore the potential molecular pathogenesis of the identified mutation.
Methods

Patients
The current study was approved by the Ethics Committee (NO. 201801001-1) of the Children's Hospital Affiliated with Nanjing Medical University (Nanjing, China). Prior to the study, written informed consent for genetic tests and publication of the case details was obtained from all adult participants and the parents or the legal guardians of children involved in the study.
Mutation analysis
Peripheral blood samples were obtained from patients and members of their families with informed consent. DNA was prepared according to standard protocols (Cat. No. CW2087, CoWin Bioscience, China).
WES was performed on the genomic DNA of the proband and members of his family (exome sequencing and bioinformatics analysis of sequencing raw data completed in Oumeng V Medical Laboratory Co., Ltd.). One microgram of genomic DNA from peripheral blood mononuclear cells (PBMCs) was used to establish the exome library. Genomic DNA was randomly sheared by sonication and then hybridized to the Agilent SureSelect Human All Exon V6 Library to enrich exonic DNA in each library, following the manufacturer's instructions. An enriched library targeting the exome was sequenced on the Illumina HiSeq 2000 platform to generate paired-end 150 bp sequences (PE150). The mean coverage of each exon was more than 100×, allowing for the examination of the selected region and sufficient depth to accurately match 99% of the targeted exome. Variant calling was performed with reference to UCSC hg19reference genome (http://genome.ucsc.edu/). 18 Single-nucleotide polymorphisms (SNPs) and small insertions or deletions (indels) were sifted using ANNOVAR (2015Dec14) with the defined parameters after the deletion of duplicated reads. 19 Short insertions or deletions (indels) altering coding sequences or splicing sites were also identified by GATK (3.3.0). 21 and MutationTaster (http://www.mutationtaster.org/) 22 were used to evaluate whether amino acid substitutions affected protein function.
Variants were identified as nonpathogenic and removed if they fit any of the following criteria:
(1) variants with an allele frequency greater than 5%; (2) variants located in introns and not affecting splicing; (3) synonymous variants without affecting splicing; or (4) variants located in the 5' or 3' untranslated region. We reviewed the functions and associated OMIM phenotypes of those genes (https://omim.org/).
Sanger sequencing was used to validate candidate variants (completed in Oumeng V Medical
Laboratory Co., Ltd.). Locus-specific primers used for PCR amplification and direct sequencing were designed using the online Primer3 program (http://primer3.ut.ee/). Then Sanger sequencing of PCR products was performed to validate the potential disease-causing variants with an ABI3500 sequencer (Applied Biosystems Inc., Foster City, CA, USA). 23
Literature review and effect prediction of ARSA c.925 mutations
A systematic literature review was performed to obtain published ARSA c.925 mutations in MLD. The detail process of literature collection and data extraction were shown in figure S1.
Amino acid conservation of ARSA protein in different species was performed by using MEGA5 and DNAMAN software. All amino acid sequences used in the conservation analysis were obtained from NCBI Web site (http://www.ncbi.nlm.nih.gov/). The effect of the amino acid changes in ARSA at p.E309 was predicted by using the web server SWISS-MODEL (https://www.swissmodel.expasy.org).
ARSA expression/mutation vector construction
The human wild-type ARSA cDNA (cloned in the pCMV6 plasmid) was purchased from RNA sequencing and subsequent bioinformatics analysis were completed by the Oumeng V Medical Laboratory. RNA sequencing was performed using the same protocol with poly-A selection of mRNA following the manufacturer's instructions (Illumina TruSeq). Paired-end 150 bp sequencing, which was performed on Illumina HiSeq 2000 instruments, generated more than 6G clean bases data for each sample. The raw reads were quality checked using FastQC. Low-quality bases were trimmed with Trimmomatic (parameters TRAILING: 3 and SLIDINGWINDOW: 4:15). 24 HISAT2 was used to compare clean reads to the reference genome (GRCh37). [25] [26] Then sequence mapping data (SAM) were converted into bam files and sorted according to mapped chromosomal location using SAMtools. 27 The software
StringTie was used to calculate the gene expression and outputted the standardized TPM format expression data of all genes in each sample. 28
Construction of WGCNAs and detection of hub genes
Expression profiling of all samples were utilized as input data to construct co-expression networks using the weighted gene WGCNA R package. 29 The pickSoftThreshold function was used to obtain a proper soft-thresholding power (β=3), where the corresponding Scale-free Topology Fit Index was above 0.9. We calculated the Pearson's correlation between modules and cell treatments to identify the relevant module. In general, the module whose absolute correlation ranked first among all the selected modules was considered the one related to phenotype. In each co-expression module, genes were ranked according to four ranking methods in Centiscape2.2 (Degree, stress, Closeness, and Radiality), the overlaps of the first 30 genes of each ranking method were defined as the hub genes. The modules were defined as key modules when they had a correlation >0 and p-value<0.05 with at least one of the four types of cell (c.925G, c.925G>A, c.925G>T, c.925G>C) and used for subsequent analysis.
Function annotation and enrichment analysis
To identify biological processes and pathways that are significantly enriched by the genes in selected modules different phenotypes, the gene list of the key modules was analyzed using the Gene Functional Classification Tool (DAVID) v6.8, which is an online tool for functional annotation and enrichment analysis to reveal biological features related to large gene lists. 30 The online tool Metascape was used to perform annotations of the hub genes from the Gene Ontology (GO) database and Kyoto Encyclopedia of Genes and Genomes (KEGG)
database. 31
Identification of protein-protein interaction networks
The gene lists from selected modules to build a protein-protein interaction (PPI) network based on BioGrid6, InWeb_IM7 and OmniPath database in online tool Metascape. Input correct species (H. sapiens), and choose "Express Analysis" for analysis. Moreover, if the network contains between 3 and 500 proteins, the "Molecular Complex Detection" (MCODE) algorithm has been applied to identify densely connected network components. All network diagrams are generated by Cytoscape. 32
Results
Clinical finding
The proband, a 27-month-old boy, was unable to stand or walk independently, had decreased lower limb muscle strength and muscle tension, and had impaired language function. He was the second boy of a healthy, nonconsanguineous couple. Before he went to the Neurology Department of Nanjing Children's Hospital, he received physical therapy for walking disability.
The proband showed decreased lower limb muscle strength and muscle tension and electrophysiological changes of multiple peripheral neurogenic lesions on EMG. Abnormal white matter symmetry signals in bilateral cerebral hemispheres were observed in MRI images of the proband ( figure 1A ).
Genetic Finding
We performed exome sequencing of the proband (II-2, figure 1B ) and other family members in a Chinese Han family. We generated more than 17 mutation, and those of the parents showed a heterozygous c.925G>A mutation (I-1, I-2, figure   1C ). His healthy brother did not inherit this mutation (II-1, figure 1C ). In previous studies, ARSA c.925G (c.925G>A, c.925G>T, c.925G>C) has been reported to cause late-infancy MLD. As shown in Table 1 , one of the 10 reported patients with MLD disease had adult MLD, and one was diagnosed with juvenile MLD; two patients have had c.925G>A homozygous mutations (including the proband found in this study), and other patients had composite heterozygous mutations at this site. 10 34-39 Transcriptome and biological analysis Twenty-nine co-expression modules were identified in the WGCNA analysis, including the grey module (ME0). According to the description of WGCNA package, genes in grey were not included in any module, so the subsequent analysis did not include them. The interactions among these 28 co-expressed modules (reflected by the connectivity of eigengenes) was
shown as a heatmap of module eigengene adjacency ( figure 3C ). Then the module-trait relationships with all traits were calculated by correlating the module's eigengenes to the traits of interest ( figure 3D ) and were used for selection of modules for downstream analysis.
The module-trait relationships showed that several modules were positively correlated with one or more cell types, and it also showed a clear distinction between the different cell types. 
Discussion
We report a boy initially manifested as inability to stand alone, decreased lower limb muscle strength and muscle tone, and electrophysiological changes in multiple peripheral neurogenic lesions on the EMG. The 2-year-old male child could not sit for a long time, and his language function was impaired. The MRI results showed white matter lesions. The results of the WES test showed that an ARSA c.925G>A homozygous mutation site carried by the child was inherited from his parents. The child diagnosed with MLD disease, from an unaffected family.
The ARSA gene c.925G>A mutation was first reported by the Kreysing research team. The team found that the c.304del C and c.925G>A mutation site was pathogenic, while heterozygous mutation site c.925G>A had no typical clinical manifestation in the parents. 40 It has been found that c.925G>A is a complex heterozygous variant with a variety of mutation sites, leading to the occurrence of MLD disease. 34 The homozygous mutation site c.925G>A was first found by Martina in a 1-year-old and a 6-month-old girl. 10 The homozygous mutation site c.925G>A found in this study is the first such report in Asia.
It has been established that highly conserved amino acid sequences have functional value and are important for the protein structure, which suggests that they play a key role in determining To further elucidate the pathogenesis of MLD disease, we transferred a wild-type and mutant vector (c.925G>A, c.925G>T, c.925G>C) into the cell, and designed a MLD missense mutant cell model. This cell mutation model approach has been successfully applied to several rare disease studies. 42 To more systematically analyze the potential effects of mutations on intracellular molecular processes, we obtained RNA-seq methods for transcriptome information from wild-type and mutant transfected cells. Based on transcriptome information, we further applied multi-dimensional system biology analysis using WGCNA combined with
Hub gene screening and PPI analysis.
WGCNA is a systematic biological method for describing gene association patterns among different samples. It can be used to identify highly synergistic gene sets based on the coherence of gene sets and the association between gene sets and phenotypes. We applied WGCNA to construct a co-expression network for exploring mutations into three different bases at c.925G (c.925G>A, c.925G>T, c.925G>C). Functional enrichment analysis of ARSA mutation c.925G>A showed enrichment in pathways of calcium ion-dependent vesicle fusion, intra-Golgi vesicle-mediated transport, metaion-binding and ion transport. In the ARSA mutation c.925G>C, the enriched pathways were associated with the mitochondrial inner membrane, vesicle-mediated transport, and calcium binding. In the ARSA mutation c.925G>T, enrichment in the carbohydrate metabolism process pathway was found.
Hub genes with high connectivity may have more important biological significance in modules. 43 PPI network analysis is an effective tool for revealing the principles of cellular organizations and functions. In this study, PPI analysis showed that the mutation of c.925G (c.925G>A, c.925G>T, c.925G>C) had more protein complexes that might interact than the control group.
The composition of these protein complexes was mostly related to energy metabolism, ion binding and other signalling pathways.
The above functional analysis showed that the three mutations of c. 
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